Pharm
Intramuscular Injection
search
Intramuscular Injection
, IM Injection, Intramuscular Vaccination Technique, Intramuscular Route
See Also
Injectable Drug Delivery Route
Emergency Medication Delivery
Subcutaneous Injection
Intravascular Injection
Technique
Injection Locations
Shoulder
(Deltoid
Muscle
)
Preferred injection site for age over 3 years
Outer thigh (Vastus lateralis
Muscle
)
Preferred injection site in under age 3 years
Upper, outer aspect of buttock (gluteal
Muscle
)
Identify landmarks and avoid sciatic nerve at inferior medial aspect
Intramuscular Injection Needle
Needle gauge: 22-25
Aqueous medications: 22 to 25 gauge
Thick solutions: 21 to 23 gauge
Needle length varies by injection site (see below)
Needles are typically 1 to 1.5 inches in teens and adults
Thigh Intramuscular Injection
Adequate needle length
Needle 1 inch: Infants and Toddlers (age <3 years)
Needle 1 to 1.25 inches: Age 3-10 years old
Needle 1 to 1.5 inches: Age 11-18 years old
Shoulder Injection
(Deltoid)
Adequate needle length
Needle 5/8 inch: Weight <130 lb (60 kg)
Needle 5/8 to 1 inch: Child <10 years old
Needle 1 inch: Weight 130-152 lb (60 kg)
Needle 1 to 1.5 inch
Women: Weight 152-200 lb (70-90 kg)
Men: Weight 152-260 lb (70-118 kg)
Needle 1.5 inch
Women: Weight >200 lb (>90 kg)
Men: Weight >260 lb (>118 kg)
Injectors arms should be at same height as patient's
Shoulder
Ensures injection will enter skin at 90 degrees (perpendicular) with less risk of injury
Injection site
Inject at central, thickest region of deltoid, below bony
Shoulder
by 2 inches (or 2-3 finger breadths)
Complications
Soft Tissue Injury
(e.g. tendon, ligament, bursa) if injection placed too high in
Shoulder
Shoulder Injury
Related to
Vaccine
Administration (SIRVA)
Bancsi (2019) Can Fam Physician 65(1): 40-2 [PubMed]
Precautions
Allow medication dose to warm to room
Temperature
before infection (reduces pain)
Patients should dispose of needles in sharps container (NOT the trash)
Avoid frequent site reuse due to injection site fibrosis risk
Rotate injection sites
Injection should be at 90 degrees to skin surface
Avoid rubbing injection area after injection
Encourage use of limb after injection to prevent freezing symptoms from dissuse
Injection in the dominant arm
Shoulder
may ensure greater use
Cool compresses may be used to reduce discomfort after injection
Consider ice to area for 10 min prior to injection
Ibuprofen
or
Acetaminophen
may be used for discomfort
Avoid premedication as very weak data suggests
Vaccine
s may be less effective after
Analgesic
s
Efficacy
Many standard IM medication uses are no more effective than their oral counterparts
Vitamin B12
Replacement
Ketorolac
(
Toradol
)
Corticosteroid
s
Ceftriaxone
in cases of refractory
Otitis Media
or
Urinary Tract Infection
s in children
Shatsky (2009) Am Fam Physician 79(4):297-300 [PubMed]
Contraindications
Relative
Bleeding Diathesis
(e.g.
Coagulopathy
or
Thrombocytopenia
)
Indications
Analgesic
s
Ketorolac
(
Toradol
)
Morphine
Hydromorphone
(
Dilaudid
)
Sedative-Hypnotic
s
Diazepam
Ketamine
Vaccination
s
Most
Vaccination
s are recommended as Intramuscular Injections
A few
Vaccine
s are subcutaneous (
MMR Vaccine
,
MPSV4
and
Varicella Vaccine
)
Zuckerman (2000) BMJ 321(7271): 1237-8 [PubMed]
DTaP
, DT, Td,
Tdap
(as well as combinations with IPV
Vaccine
,
Hib Vaccine
,
Hepatitis B Vaccine
)
Hib Vaccine
IPV
Vaccine
(may be given subcutaneously)
Gardasil
Vaccine
Hepatitis A Vaccine
Hepatitis B Vaccine
Serotype B Meningococcal Vaccine
Quadrivalent Meningococcal Conjugate Vaccine
(MenACWY)
Pneumococcal Conjugate Vaccine
(
PCV13
)
Polyvalent pneumococcal Vaccine
(
Pneumovax 23
, may be given subcutaneously)
Varicella Zoster Virus Vaccine
Rabies Vaccine
Covid-19 Vaccine
Sex
Hormone
s
Testosterone
Estradiol
Depo Provera
Lupron
Antibiotic
s
Penicillin
Ceftriaxone
Miscellaneous
Epinephrine
(e.g.
Anaphylaxis
)
Interferon Beta
(
Multiple Sclerosis
)
Methylprednisolone
(
Depo-Medrol
)
Resources
Vaccination
https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html
References
(2021) Presc Lett 28(12):70
(2021) Presc Lett 28(3): 13-4
Type your search phrase here